Insights into the chemistry and biology of the I-Ag7 class II molecule

Research in Immunology

Volumn 148, Issue 5, 1997, Pages 291-301

  Carrasco Marin, E ^a   Kanagawa, O ^a   Unanue, E R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; CHEMICAL STRUCTURE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0030806139     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(97)87237-9     Document Type: Article

References (34)

1. Acha-Orbea, H. & McDevitt, H.O. (1987), The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc. Natl. Acad. Sci. USA, 84, 2435-2439.
2. Allen, P.M., Matsueda, G.R., Evans, R.J., Dunbar, J.B. Jr., Marshall, G.R. & Unanue, E.R. (1985), Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature (Lond.), 327, 713-715.
3. Aston-Rickardt, P. & Tonegawa, S. (1994), A differential-avidity model for T-cell selection. Immunol. Today, 15, 362-366.
4. Babbitt, B.P., Matsueda, G.R., Haber, E., Unanue, E.R. & Allen, P.M. (1985), Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (Lond.), 317, 359-361.
5. Buckner, J., Kwok, W.W., Nepom, B. & Nepom, G.T. (1996), Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions. J. Immunol., 157, 4940-4945.
6. Carrasco-Marin, E., Shimizu, J., Kanagawa, O. & Unanue, E.R. (1996), The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol., 156, 450-458.
7. Castaño, L. & Eisenbarth, G.S. (1990), Type I diabetes: chronic autoimmune disease of human and rat. Annu. Rev. Immunol., 8, 647-679.
8. Chicz, R.M., Urban, R.G., Lane, W.S., Gorga, J.C., Stern, L.J., Vignali, D.A. & Strominger, J.L. (1992), Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature (Lond.), 358, 764-768.
9. Elias, D., Reshef, T., Birk, S.O., van der Zee, R., Walker, M.D. & Cohen, I.R. (1991), Vaccination against autoimmune mouse diabetes with a T cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA., 88, 3088-3091.
10. Fairchild, P.J., Wildgoose, R., Atherton, E., Webb, S. & Wraith, DC (1993), An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol., 5, 1151-1158.
11. Fremont, D.H., Hendrickson, W.A., Marrack, P. & Kappler, J. (1996), Structures of an MHC class II molecule with covalently bound single peptides. Science, 272, 1001-1004.
12. Ghosh, P., Amaya, M., Mellins, E. & Wiley, D.C. (1995), The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature (Lond.), 378, 457-462.
13. Hattori, M.,Buse, J.B., Jackson, R.A., Glimcher, L., Dorf, M.E., Minani, M., Makino, S., Moriwaki, K., Kuzuya, H., Imura, H., Strauss, W.M., Seidman, J.G. & Eisenbarth, G.S. (1986), The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science. 231, 733-735.
14. d. Science, 256, 1817-1820.
15. Hurtenbach, U., Lier, E., Adorini, L & Nagy, Z.A. (1993), Prevention of autoimmune diabetes in nonobese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide. J. Exp. Med., 177, 1499-1504.
16. *0201) molecule. Int. Immunol., 6, 453-461.
17. Lacy, P.E. & Kostianovsky, M. (1967), Method for isolation of intact islets of Langerhans from the rat pancreas. Diabetes, 16, 35-39.
18. Milich, D.R., Jones, J.E., McLachlan, A., Houghten, R., Thornton, G.B. & Hughes, J.L. (1989), Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants : influence of peptide-MHC interaction. J. Immunol., 143, 3148-3156.
19. Nelson, C.A., Petzold, S.J. & Unanue, E.R. (1993), Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Nat. Acad. Sci. USA, 90, 1227-1231
20. Nelson, C.A., Petzold, S.J. & Unanue, E.R. (1994), Peptides determine the lifespan of class II molecules in the antigen-presenting cell. Nature (Lond.), 371, 250-252.
21. k. Proc. Natl. Acad. Sci. USA, 89, 7380-7383.
22. k. Immunol. Rev., 151, 81-105.
23. Nepom, G.T, (1993), Immunogenetics and IDDM. Diabetes Rev., 1, 93-103.
24. Reich, E-P., von Grafenstein, H., Barlow, A., Swenson, K.E., Williams, K. & Janeway, C.A. (1994), Self peptides isolated from MHC glycoproteins of nonobese diabetic mice. J. Immunol., 152, 2279-2288.
25. Ridgway, W.M., Fasso, M., Lanctot, A., Garvey, C., & Fathman, C.G. (1996), Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med., 183, 1657-1662.
26. Rudensky, A.Y., Preston-Hurlburt, P., Hong, S-C., Barlow, A. & Janeway, C.A. (1991), Sequence analysis of peptides bound to MHC class II molecules. Nature (Lond.), 353, 622-627.
27. Sadegh-Nasseri, S. & Germain, R.N. (1991), A role for peptide in determining MHC class II structure. Nature (Lond.), 353, 167-170.
28. Shimizu, J., Carrasco-Marin, E. Kanagawa, O, & Unanue, E.R. (1995), Relationship between β cell injury and antigen presentation in NOD mice. J. Immunol., 155, 4095-4099.
29. Shimizu, J., Kanagawa, O. & Unanue, E.R. (1993), Pres-entation of β-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. J. Immunol., 151, 1723-1730.
30. Sprent, J, Lo, D., Gao, K. & Ren, Y.Y. (1988), T cell selection in the tymus. Immunol. Rev., 101, 173-190.
31. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L. & Wiley, D.C. (1994), Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature (Lond.), 368, 215-221.
32. Todd, J.A., Bell, J.I. & McDevitt, H.O. (1987), HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature (Lond.), 329, 599-604.
33. Ziegler, H. K & Unanue, E.R. (1981), Identification of a macrophage antigen processing event required for I-region-restricted antigen presentation to T lymphocytes. J. Immunol, 127, 1869-1875.
34. Ziegler, H. K & Unanue, E.R. (1982), Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc. Natl. Acad. Sci. USA, 79, 175-178.